Cargando…
SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial
BACKGROUND: Emerging evidence suggests modulating the microbiota in the large bowel of patients with chronic kidney disease (CKD) through pre- and/probiotic supplementation may inhibit the development of key nephrovascular toxins. To date, quality intervention trials investigating this novel treatme...
Autores principales: | Rossi, Megan, Johnson, David W, Morrison, Mark, Pascoe, Elaine, Coombes, Jeff S, Forbes, Josephine M, McWhinney, Brett C, Ungerer, Jacobus PJ, Dimeski, Goce, Campbell, Katrina L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094543/ https://www.ncbi.nlm.nih.gov/pubmed/24996842 http://dx.doi.org/10.1186/1471-2369-15-106 |
Ejemplares similares
-
Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial
por: McFarlane, Catherine, et al.
Publicado: (2021) -
Policy change to improve pathology turnaround time and reduce costs – possible to do both?
por: Dimeski, Goce, et al.
Publicado: (2013) -
Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion
por: Goupil, Rémi, et al.
Publicado: (2015) -
Maternal Metyrapone Use During Breastfeeding: Safe for the Breastfed Infant
por: Duke, Madeline E, et al.
Publicado: (2019) -
Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children
por: Gwee, Amanda, et al.
Publicado: (2020)